NEW YORK (GenomeWeb) – The US Food and Drug Administration has authorized the use of a PCR-based test for the diagnosis of the Ebola Zaire virus.

The test was developed by the US Department of Defense and uses Thermo Fisher Scientific Life Technologies' TaqMan technology. It is authorized by FDA for use in laboratories "designated by DoD to help facilitate effective responses to the ongoing Ebola outbreak detected in West Africa," a spokesperson for the FDA said in an email to GenomeWeb Daily News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.